Day Zero Diagnostics to Be Acquired by bioMérieux
bioMérieux is acquiring the assets of Day Zero Diagnostics to enhance its capabilities in NGS and rapid infectious disease diagnostics.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
